Fondaparinux Sodium: Your Comprehensive Guide to Anticoagulant Therapy and Prevention
Discover the uses, benefits, and applications of this critical synthetic pentasaccharide anticoagulant.
Get a Quote & SampleProduct Core Value
Fondaparinux Sodium
Fondaparinux sodium is a vital synthetic pentasaccharide anticoagulant, chemically related to low molecular weight heparins. It plays a crucial role in modern medicine for preventing and treating serious thromboembolic conditions.
- Understanding the importance of 'fondaparinux sodium suppliers price' is key for many healthcare providers and institutions.
- The 'prevention of deep vein thrombosis' is a primary application, particularly for patients recovering from orthopedic surgeries.
- As a selective 'Factor Xa inhibitor', it offers targeted therapeutic action.
- The high purity of Fondaparinux Sodium (≥99.00%) ensures its efficacy and safety in clinical settings.
Key Advantages
Therapeutic Efficacy
Fondaparinux sodium is proven effective in both the 'treatment of deep vein thrombosis' and the 'treatment of pulmonary embolism', offering a reliable solution for patients.
Reduced HIT Risk
Compared to some other anticoagulants, Fondaparinux sodium offers a substantially lower risk of heparin-induced thrombocytopenia (HIT), making it a safer option for many.
Targeted Action
Its mechanism as a 'synthetic pentasaccharide inhibitor' provides a precise action against Factor Xa, crucial for managing blood clotting.
Key Applications
Post-Surgical Care
Essential for 'prevention of deep vein thrombosis' following major surgeries like hip or knee replacements, ensuring patient recovery.
Thrombosis Treatment
A critical component in the 'treatment of deep vein thrombosis' and 'treatment of pulmonary embolism', often used in conjunction with other therapies.
Pharmaceutical Manufacturing
As a high-purity active pharmaceutical ingredient, it is sought after by 'fondaparinux sodium manufacturers' for drug formulation.
Medical Research
Its well-defined properties make it valuable in research focused on anticoagulation and cardiovascular health, exploring 'fondaparinux sodium CAS 114870-03-0' implications.